The MLB non-waiver trade deadline is this Friday. It’s a frenzied time of year, with baseball fans glued to social media to see who their favorite team has picked up — or traded away.
Fans of the Washington Nationals are no different, with rumors the team has been attached to acquiring big-name relievers such as Aroldis Chapman, Craig Kimbrel, Jonathan Papelbon and former Nats-Tyler Clippard, who was traded to the division-rival New York Mets on Monday.
It’s easy to assume, then, that the Nats are looking for bullpen help. The anchor of the bullpen, Drew Storen, has All-Star qualifications this season, but the rest of the equation is still a work in progress. Matt Thornton, quietly, has been excellent, but Tanner Roark has been wildly inconsistent, Blake Treinen was demoted and David Carpenter, a basement-bargain pick-up, was disabled.
So it only seems that a deal for consistent reliever would be in the offing.
But looking at the roster, it’s hard to determine, other than that, what the Nats really need.
We still haven’t seen the real Nats on the field this season with all the injuries. It’s easy to see Anthony Rendon back in uniform, and imagine Denard Span, Jayson Werth and Ryan Zimmerman joining the team as well to finally field the team Mike Rizzo thought he put together at the start of the season.
Many have been trying to make the point that the Nats are in first place without all these starters on offense, so their re-joining the team will be better than any trade deadline acquisition — without giving up any prospects to do so.
But what are the Nats getting with these guys coming back to the lineup? Rendon is still young and should reasonably perform up to standards once he gets him MLB timing back. Span was performing admirably before his balky back required a now-lengthy stay on the DL. But Werth and Zimmerman have been accumulating injuries the past several seasons and there’s really no way to tell what they are going to provide to the offense until they are back in the lineup.
We can’t just assume they will both return to their pre-injury performance level. Werth’s age, and the nature of Zimmerman’s injury, really leave the door open to what level of play they’ll bring once they return to the field.
It’s one thing for a fan to look at the sheer number of players returning from the DL and assume things will be better once all these players are back in the lineup. And there’s no doubt Rendon and Span should provide a boost to the top of the order.
But counting on Werth and Zimmerman to provide pre-DL production is a risky move for anyone looking at the roster with an analytic approach.